Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxygen targets in ICU patients with SIRS
NCT02321072Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2015
- Primary completion
- Jan 2019
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of oxygen in Systemic Inflammatory Response Syndrome (SIRS), sponsored by Amsterdam University Medical Center. Started Feb 2015; status: completed.
02
Drugs
oxygen
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT02321072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02321072.